The past, present and future of potential small-molecule drugs targeting p53-MDM2/MDMX for cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The past, present and future of potential small-molecule drugs targeting p53-MDM2/MDMX for cancer therapy

Published:2019-08 Issue: Volume:176 Page:92-104
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Liu Yao,Wang Xiaohui,Wang Guan,Yang Yushang,Yuan Yong,Ouyang Liang^ORCID

Funder

National Key R&D Program

National Natural Science Foundation of China

Sichuan Science and Technology Program

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference88 articles.

1. MDM2 and MDMX: alone and together in regulation of p53;Shadfan;Transl. Cancer Res.,2012

2. p53 and human cancer: the first ten thousand mutations;Hainaut;Adv. Cancer Res.,1999

3. P53 is a tumor suppressor gene;Levine;Cell,2004

4. AKT-dependent phosphorylation of Niban regulates nucleophosmin and MDM2-mediated p53 stability and cell apoptosis;Ji;EMBO Rep.,2012

5. c-Abl phosphorylation of Mdm2 facilitates Mdm2-Mdmx complex formation;Waning;J. Biol. Chem.,2011

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular, Structural Basis, and Recent Progress for Targeting Murine Double Minute X (MDMX) in Tumors;Journal of Medicinal Chemistry;2024-08-26

2. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches;Molecular Cancer;2024-07-25

3. Small molecule NMD and MDM2 inhibitors synergistically trigger apoptosis in HeLa cells;Molecules and Cells;2024-07

4. Synthesis and biological evaluation of 4-imidazolidinone–containing compounds as potent inhibitors of the MDM2/p53 interaction;European Journal of Medicinal Chemistry;2024-04

5. Single-cell RNA sequencing integrated with bulk RNA sequencing analysis identifies a tumor immune microenvironment-related lncRNA signature in lung adenocarcinoma;BMC Biology;2024-03-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3